Want to see HK:1858 full AI Analyst Report?
1858 Stock Chart & Stats
HK$15.39
-HK$0.21(-2.63%)
At close: 4:00 PM EST
HK$15.39
-HK$0.21(-2.63%)
Day’s Range― - ―
52-Week RangeHK$8.12 - HK$20.82
Previous CloseN/A
Volume218.00K
Average Volume (3M)1.20M
Market Cap
HK$5.65B
Enterprise ValueHK$2.62K
Total Cash (Recent Filing)HK$2.10B
Total Debt (Recent Filing)HK$2.23M
Price to Earnings (P/E)19.8
Beta1.25
Next Earnings
Aug 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.42%
Share Statistics
EPS (TTM)0.70
Shares Outstanding95,140,500
10 Day Avg. Volume978,626
30 Day Avg. Volume1,198,522
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)1.71
Price to Sales (P/S)4.89
P/FCF Ratio14.53
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.88
Revenue Forecast (FY)HK$1.27B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetExtremely low leverage provides durable financial flexibility: the company can fund working-capital swings, R&D, or targeted capex without issuing debt, withstand procurement cycles in hospitals, and pursue opportunistic investments or partnerships over the next several months.
Resilient Profitability And MarginsSustained gross and net margins indicate pricing power and operational efficiency typical of established medical-device makers; margins help preserve earnings through revenue swings, support reinvestment in product development, and maintain capacity to pay dividends or fund strategic initiatives.
Strong TTM Cash GenerationRobust trailing-twelve-month operating and free cash flow that covers most net income enhances self-funding ability, reduces reliance on external capital, and supports steady operations, inventory funding and selective capex—strengths that persist across typical multi-month cycles.
Bears Say
Revenue Volatility And Recent DeclineMeaningful top-line swings and a sharp 2024 decline undermine durable growth visibility: inconsistent demand from hospital procurement or distributor ordering makes forecasting, capacity planning and R&D prioritization harder, raising execution risk over coming quarters.
Choppy Historical Cash FlowPeriodic negative operating and free cash flows point to working-capital swings or investment cycles that can strain liquidity; even with low debt, repeated cash volatility complicates sustaining dividends, funding growth or responding to unexpected costs without altering operations or reserves.
Limited Recurring Revenue VisibilityAbsence of disclosed recurring revenue streams (services, consumables, maintenance) and an unclear channel mix implies heavy reliance on one-off device sales to hospitals, increasing cyclicality and customer-concentration risk and reducing predictability of long-term revenue and lifetime customer value.
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H News
1858 FAQ
What was Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s price range in the past 12 months?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H lowest stock price was HK$8.12 and its highest was HK$20.82 in the past 12 months.
What is Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s market cap?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s market cap is HK$5.65B.
When is Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s upcoming earnings report date?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s upcoming earnings report date is Aug 29, 2026 which is in 24 days.
How were Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s earnings last quarter?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H released its earnings results on Apr 29, 2026. The company reported HK$0.186 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H overvalued?
According to Wall Street analysts Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s price is currently Overvalued.
Does Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H pay dividends?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H pays a Semiannually dividend of HK$0.172 which represents an annual dividend yield of 4.42%. See more information on Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H dividends here
What is Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s EPS estimate?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H have?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H has 95,140,500 shares outstanding.
What happened to Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s price movement after its last earnings report?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H reported an EPS of HK$0.186 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.409%.
Which hedge fund is a major shareholder of Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:1858
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
99.89%
12-Months-Change
Fundamentals
Return on Equity
4.42%
Trailing 12-Months
Asset Growth
10.60%
Trailing 12-Months
Company Description
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H
Beijing Chunlizhengda Medical Instruments Co., Ltd. functions as a prominent entity within the orthopedic medical device industry, dedicated to the development, manufacturing, and distribution of surgical implants, instruments, and associated medical supplies throughout the People's Republic of China. Its core product range features implantable orthopedic solutions, specifically comprising joint prostheses and spinal treatment products. The company predominantly distributes its merchandise via an expansive network of distributors, through original design manufacturing (ODM) and original equipment manufacturing (OEM) partnerships under the 'Chunli' label, and by direct sales to healthcare institutions. Beyond its domestic operations, the firm also engages in exporting its products to various countries globally. Established in 1998, its corporate headquarters are situated in Beijing, China.
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H (1858) Earnings & Revenues
Technical Analysis
MicroPort Scientific
―
Peijia Medical Ltd.
―
Zylox-Tonbridge Medical Technology Co., Ltd. Class H
―
AK Medical Holdings Ltd.
―
MicroTech Medical (Hangzhou) Co., Ltd. Class H
―